Real-world management and patient perspectives on QOL with neuroendocrine tumors: An ANZ perspective.

Michael, Michael; Chantrill, Lorraine; Price, Timothy; Chan, David L; Wakelin, Kate; Cummins, Meredith

Michael, Michael; Chantrill, Lorraine; Price, Timothy; Chan, David L; Wakelin, Kate; Cummins, Meredith.

Michael M; Neuroendocrine Unit, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Chantrill L; Illawarra Shoalhaven Local Health District, Wollongong, New South Wales, Australia.
Price T; Queen Elizabeth Hospital, Adelaide, South Australia, Australia.
Chan DL; Royal North Shore Hospital, Sydney, New South Wales, Australia.
Wakelin K; Northern Clinical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
Cummins M; NeuroEndocrine Cancer Australia, Melbourne, Victoria, Australia.

Asia Pac J Clin Oncol ; 17 Suppl 2: 3-10, 2021 04.

Article in English | MEDLINE | ID: covidwho-1191208

Subject(s)

Neuroendocrine Tumors; Quality of Life; Humans; Neuroendocrine Tumors/drug therapy

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Quality of Life / Neuroendocrine Tumors Limits: Humans Language: English Journal: Asia Pac J Clin Oncol Journal subject: Neoplasms Year: 2021 Document Type: Article Affiliation country: Ajco.13587

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google